Proactive Investors - Run By Investors For Investors

RYAH Medtech wins CE mark for RYAH vaporizer and sets sights on European market

Jordan Medley, who heads product operations, says the CE mark is a key milestone for RYAH as it expects to shortly initiate a launch in Europe
The Ryah vaporizer
The RYAH dry herb vaporizer is the first device that allows patients to precisely control dosage and temperature

RYAH Medtech Inc announced Thursday that its novel dose-measuring dry herb RYAH vaporizer has received a CE mark from the British Standards Institute.

The certification is a critical part of New York-based RYAH Medtech’s expansion strategy in Europe.

The company hopes to penetrate the European region with its RYAH vaporizer, proprietary dry herb cartridges and real-time data analytics solution.

READ: Vaporizer-maker RYAH Medtech inks Canadian distribution agreement

RYAH Medtech’s vaporizer is the first device that allows patients to precisely control dosage and temperature.    

“Countries around the world are embracing the health benefits of dry herb medicine and we believe the RYAH vaporizer will be an essential tool to add legitimacy to the international market,” says Jordan Medley, head of product operations at RYAH Medtech. “The user-generated, HIPAA-compliant data that RYAH collects is expected to be instrumental in enabling physicians to make educated recommendations to help patients optimize their relief and avoid negative experiences from medicating with plant-based medicine.”

Medley says the CE mark paves the way for the company to “shortly initiate” the RYAH vaporizer’s launch in Europe.

A recent report by Prohibition Partners said Europe is likely become the world’s largest legal plant-based treatment market over the next five years.

RYAH said the company plans to roll-out several clinical delivery mechanisms for dose measuring and data collection.

The RYAH cloud solution provides doctors and patients with the ability to track which plant strains work best for their specific needs, while continuously collecting data for growers, pharmacies, laboratories and pharma companies to help improve the effectiveness of medical plant dosing.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full RYAH profile View Profile

Ryah Medtech Inc Timeline

Related Articles

A visual representation of a drug candidate working in a dog
January 29 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
cannabis plant
June 17 2019
The company recently underwent a brand identity redesign and unveiled a new wknd! product line consisting of pre-rolls, vape pens and cannagars which it will launch in July in Washington State

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use